Bristol-Meyers Squibb In Class Action Over $2B Fraud
Drug maker Bristol-Meyers Squibb misled investors in a multi-billion dollar scheme to exaggerate demand its most popular products, according to a complaint filed Wednesday in federal court....To view the full article, register now.
Already a subscriber? Click here to view full article